Navigation Links
Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results Webcast And Conference Call To November 2, 2012 Due To Hurricane Sandy
Date:10/30/2012

MONTREAL, Oct. 30, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has decided to reschedule its webcast and conference call to discuss financial results for the 2012 third quarter, which was previously scheduled for Wednesday, October 31, 2012 at 8 a.m. ET, due to the severe weather conditions and power outages associated with Hurricane Sandy. The webcast and conference call has been rescheduled for November 2, 2012 at 8 a.m. ET and the financial results will be issued at 6:00 a.m. ET.

The dial-in number to participate on this call is (877) 281-0402, confirmation code 39252322.  International callers should dial (631) 813-4869, confirmation code 39252322. A replay will be available approximately two hours following the conclusion of the conference call to Friday, November 9, 2012, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 39252322.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.  More information about Valeant can be found at

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
2. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
3. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
4. Valeant Pharmaceuticals To Syndicate Incremental Loans
5. Valeant Pharmaceuticals Announces Management Change
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
8. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
9. Valeant Pharmaceuticals To Host Investor Day
10. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
11. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  A recently published clinical study conducted at ... , demonstrates that 3D mammography (breast tomosynthesis) significantly ... The study, "Implementation of Breast Tomosynthesis in ... by Stephen L. Rose , MD, ... American Journal of Roentgenology (AJR). The AJR is ...
(Date:5/23/2013)... JERUSALEM , May 23, 2013  Hadasit Bio-Holdings ... portfolio of biotech companies, based on intellectual property ... Israel ,s foremost medical research center, ... Neurosciences Ltd., received significant funding from the Israeli ... Chief Scientist (OCS) to support product development and ...
(Date:5/23/2013)... May 23, 2013  The need to add ... continuum was highlighted prominently at the 108 th ... (AUA), in San Diego.  According to SonaCare Medical, ... ultrasound (HIFU) technology, the need for image-guided technologies ... urologists to consider minimally invasive ablative treatments, was ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6
... -- MUMBAI, India, October 20, 2010 ... ... (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
... (Nasdaq: STXS ) announced today that ... and educational video sharing web portal for the ... electrophysiology (EP) and interventional cardiology (IC) procedures from ... Network utilizes Stereotaxis, state-of-the-art Odyssey technology platform to ...
Cached Medicine Technology:Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 2Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 3Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 4Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 5Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 6Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 7Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 8Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 2Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 3Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 4
(Date:5/24/2013)... mutations central to the development of infantile myofibromatosis (IM)a ... and soft tissuemay provide new therapeutic targets, according to ... Sinai. The findings, published in the American Journal ... options for this debilitating disease, for which the only ... tumors. , IM is an inheritied disorder that develops ...
(Date:5/24/2013)... Mike Stoler believes that there is much to be ... York. That’s why he hosts “Building New York—New ... And that’s why he invited Robert Glazer, Chief Executive ... single specialty practice in the greater New York area, ... and sub-specialists service communities throughout New York and New ...
(Date:5/24/2013)... May 24, 2013 6Webs.com has educated ... out a home security monitoring provider. The ... 6Webs.com the useful resource consumers prefer for unbiased and ... their evaluations of the leading wireless home security system ... are rated on a number of key factors including ...
(Date:5/24/2013)... Bethesda, MD (PRWEB) May 24, 2013 ... to its growing base of clients. As a result ... reports a presence in 20 states around the ... providing medical transcription services to the healthcare industry ... nurses who use their years of clinical work ...
(Date:5/24/2013)... (HealthDay News) -- The number of U.S. patients ... time in an emergency room has increased by ... The study, conducted by researchers at the George ... Services in Washington, D.C., found that patients wait ... before being admitted to the ICU. The researchers ...
Breaking Medicine News(10 mins):Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2
... Reporter , WEDNESDAY, Oct. 13 (HealthDay News) -- People taking ... or treat osteoporosis may be at risk for a rare ... warned Wednesday. Bisphosphonates work by inhibiting bone loss ... Whether bisphosphonates are the cause of these rare thigh fractures ...
... to give back to the cancer communities in the ... Society for Radiation Oncology (ASTRO) is partnering with Mama,s ... survivorship issues. , Mama,s Kitchen will work with ASTRO ... 52nd Annual Meeting, scheduled for October 31-November 4, 2010, ...
... Gerontological Society of America (GSA) and the National ... PhD, and Tony Noice, PhD, of Elmhurst College as the ... in Creativity and Aging . This award recognizes and ... in the field of creativity and aging shifted the conceptual ...
... By Serena Gordon HealthDay Reporter , TUESDAY, Oct. ... five siblings of children with autism may have subtler problems ... 3,000 children. What isn,t yet clear is if these ... or exactly what type of intervention, if any, might be ...
... Douglas A. Jabs, MD, MBA, Professor and Chair of ... Associates, and Dean for Clinical Affairs at The Mount ... prestigious Jackson Memorial Lecture at the 2010 Annual Meeting ... be published in the November issue of the ...
... systems and symbols on the fronts of food packaging ... four nutrients of greatest concern calories, saturated fat, ... from the Institute of Medicine. These food components ... health problems affecting many Americans, including obesity, heart disease, ...
Cached Medicine News:Health News:Bone Drugs Linked to Rare Fractures, FDA Warns 2Health News:Bone Drugs Linked to Rare Fractures, FDA Warns 3Health News:Noices to receive 2010 Gene D. Cohen Award 2Health News:Siblings of Autistic Children May Also Have Subtle Traits 2Health News:Siblings of Autistic Children May Also Have Subtle Traits 3Health News:Douglas A. Jabs, M.D., honored with Jackson Memorial Lecture by the American Academy of Ophthalmology 2Health News:Douglas A. Jabs, M.D., honored with Jackson Memorial Lecture by the American Academy of Ophthalmology 3Health News:Nutrition rating enhancing front-of-package nutrition rating systems and symbols: Phase 1 2
... Atlas monitor is a low-cost, multi-parameter monitor ... procedures, and surgery. The large display provides ... visible from across the room. The intuitive ... operate the monitor in just minutes., ...
... needed for quality, comprehensive portable and bedside ... allows you to see up to four ... touch screen allows easy navigation through menus ... temperature., ,Standard features include two channels ...
... anesthesia monitor., ,The Cardiocap/5 is ... use in the operating room, ambulatory ... The Cardiocap/5 offers full vital signs ... oxygenation and circulation to advanced airway ...
... for Clinical Professionals and Researchers., ,S/5 Collect ... and efficient way to collect data from Datex-Ohmeda ... days at selectable time intervals. With S/5 Collect ... the monitor via an interface cable or connect ...
Medicine Products: